Patricia A. Marken, Pharm.D., FCCP
Associate Dean for Student Affairs
UMKC School of Pharmacy
2464 Charlotte Street
Kansas City, MO 64108
Phone: (816) 235-2195
Patricia Marken is professor of pharmacy practice and administration and psychiatry at the UMKC Schools of Pharmacy and Medicine. She has been the School of Pharmacy’s associate dean for student affairs since 2011.
Dr. Marken completed her B.S. in pharmacy at Dalhousie University, followed by a Canadian Society of Hospital Pharmacists accredited hospital pharmacy residency. She completed her doctor of pharmacy at the Medical University of South Carolina and an ASHP accredited residency and fellowship in psychiatric pharmacy at the University of Tennessee. Dr. Marken has been a board certified psychiatric pharmacist since 1996 and a fellow in ACCP since 2000. She received ten UMKC teaching awards and published over 50 peer-reviewed articles and book chapters on psychiatric pharmacotherapy and pharmacy education. Dr. Marken has held leadership roles in AACP, ASHP and ACCP. She was chair of the CNS PRN within ACCP and ASHP network facilitator for Psychiatry/Neurology within the Section of Clinical Specialists. Within AACP, Dr. Marken is currently the chair of the Section of Teachers of Pharmacy Practice and Administration, chair elect-designee of the Council of Sections and member-elect to the Board of Directors. She chaired the Task Force on Faculty Workforce and was a member of the ad hoc Accreditation Standards and Guidelines Review Committee, Entry-level Practice Expectations Committee, Membership Committee Resolutions Committee, Recruitment and Retention Faculty Joint Task Force, Distinguished Pharmacy Educator Award Committee, Council of Faculties Nominating Committee and the Council of Faculties Standing Rules Committee. Her current professional interests include curriculum development, especially in the areas of communication and health information technology and student and programmatic assessment.
- Rho Chi Teacher of the Year, 2009
- Marken, P.A. Standardized Patients to Teach Difficult Conversations to Interprofessional Health Care Teams. American Journal of Pharmaceutical Education 2010:74; Article 120.
- Goggin K, Hawes SM, Duval ER, Spresser CD, Martinez DA, Lynam I, Barnes A, Hinton-Dampf AM, Murphy ME, Marken PA, Catley D. Developing a motivational interviewing based patient-centered counseling skills in Pharm.D. students: A multidisciplinary approach. American Journal of Pharmaceutical Education 2010:74;Article 70.
- Marken PA, Schneiederhan M, Munro S. Evaluation of Psychiatric Illness. In: DiPiro JT, Talbert RL, Yee G et al (eds). Pharmacotherapy: A Pathophysiologic Approach. Seventh Edition, McGraw-Hill, 2008: 1021-1028.
- Stoner SC, Nelson LA, Lea JW, Marken PA et al. Historical review of carbamazepine for the treatment of bipolar disorder. Pharmacotherapy 2007; 27:66-8.
- Marken PA, Pies R. Emerging Treatments for Bipolar Disorder: safety and adverse effect profiles. Ann Pharmacotherapy 2006;40:276-85.
Co-Investigator, “The use of human simulation/standardized patients to teach inter-professional competencies in IPV prevention,” Funded for $10,000 by Association for Teaching, Prevention and Research, 2007.